Vetter Pharma Fertigung GmbH & Co. KG Launches New Subsidiary

Vetter Pharma International GmbH (VPI) will Focus on Global Sales, Service

20-Mar-2009 - Germany

Vetter Pharma-Fertigung GmbH & Co. KG (VPF) announced the Formation of a new subsidiary, Vetter Pharma International GmbH (VPI). With a scheduled launch date of April 1, 2009, VPI will be responsible for all Vetter sales, marketing and customer service activities on a worldwide level.

Peter Soelkner has been named Managing Director, and Oskar Gold will serve as Vice President of the new entity. Headquarters will be in Ravensburg, Germany, and Vetter Pharma International USA Inc. will be located in Yardley, PA.

“The formation of VPI allows us to better position ourselves as a worldwide leader in pre-filled aseptic injection solutions,” Soelkner said. “By creating an entity that focuses exclusively on sales, marketing and customer service on a global level, Vetter will move significantly closer to the international market and can build even stronger relationships with our clients and prospects throughout the world.”

VPF, which previously has managed all of Vetter’s sales, services and manufacturing activities under a single corporate umbrella, will now focus exclusively on the company’s manufacturing and pharmaceutical operations. VPF will continue to be a strong partner for pharmaceutical and biotech companies, providing high quality pharmaceutical services that support the supply chain of aseptically pre-filled injectable products, from clinical development to market launch to ongoing delivery worldwide, Soelkner said.

Other news from the department business & finance

Most read news

More news from our other portals

So close that even
molecules turn red...